Ammonium 5-methoxy-2-methyl-4-(3-oxobutanamido)benzenesulfonate

We are Ammonium 5-methoxy-2-methyl-4-(3-oxobutanamido)benzenesulfonate CAS:72705-22-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Ammonium 5-methoxy-2-methyl-4-(3-oxobutanamido)benzenesulfonate
 
Boiling point: 586.3ºC at 760 mmHg
Flash point: 308.4ºC
 
Use
Intermediate of dyes and organic pigments.
 

Items of Analysis Standard of Analysis Test Results
Appearance Off-white powder Conforms
Assay ≥95.0% 95.1%
Purity(HPLC) ≥99.0% 99.2%
Insolubles ≤0.5% 0.02%
Conclusion Conforms to Factory Standard
 

Ammonium 5-methoxy-2-methyl-4-(3-oxobutanamido)benzenesulfonate


Related News: Countries and territories that have confirmed cases: Thailand, Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia, France, the United States, South Korea, Germany, the United Arab Emirates, Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri Lanka, Finland, Sweden and Spain.132-68-3 Countries and territories that have confirmed cases: Thailand, Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia, France, the United States, South Korea, Germany, the United Arab Emirates, Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri Lanka, Finland, Sweden and Spain.(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.3-Aminophthalic acid International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.

Related Products
Product Name
potassium tetracyanomercurat View Details
2-(3-bromophenyl)triphenylene View Details
O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium Hexafluorophosphate View Details
4-[(6-Chloro-1,3-benzoxazol-2-yl)oxy]phenol manufacturer Cytidylic acid manufacturer 5-Fluoro-2-oxindole manufacturer Biphenyl-4-yl-(4-carbazol-9-yl-phenyl)-amine manufacturer 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine manufacturer